Patents
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
06/2010
06/17/2010US20100152098 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
06/17/2010US20100150836 Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging
06/16/2010EP2195328A1 Certain chemical entities, compositions, and methods
06/16/2010CN101735229A Tetrahydroisoquinoline compounds and preparation method and application thereof
06/15/2010US7737295 1-benzyl-4-[4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl]imidazolidin-2-one; cholesteryl ester transfer protein inhibitor; raising HDL-cholesterol, reducing LDL-cholesterol; atherosclerosis, antiinflammatory agent; synergistic mixture with other active ingredients
06/15/2010CA2521647C Novel hydroxamates as therapeutic agents
06/10/2010WO2010064212A1 Method for obtaining an optically pure 1,2,3,4 tetrahydro-isoquinoline derivative
06/10/2010US20100145048 Compounds for the treatment of inflammatory disorders
06/10/2010US20100144821 Compounds and methods for treating protein folding disorders
06/10/2010US20100144785 Fungicide n-6-membered fused (hetero) aryl-methylene-n-cycloalkyl carboxamide derivatives
06/10/2010US20100144713 6-and 7-amino isoquinoline compounds and methods for making and using the same
06/10/2010CA2744711A1 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
06/09/2010CN1863789B Substituted isoquinolinones
06/09/2010CN101723896A Tyrosine derivative histone deacetylases inhibitor and application thereof
06/09/2010CN101723895A Method for producing 2-alkyl-2H-(halo)isoquinoline-1-ketone
06/08/2010US7732446 such as (1-Aminomethyl-6,8-dimethoxy-isoquinolin-4-yl)-(3,4-dihydro-1H-isoquinolin-2-yl)-methanone, that have advantageous potency, stability, selectivity, toxicity and/or pharmacokinetic properties
06/08/2010CA2389300C 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
06/03/2010US20100137359 Caspase inhibitors and uses thereof
06/02/2010EP2190808A1 Leukotriene b4 inhibitors
06/01/2010US7728137 with Tris(2-bromo-6-pyridyl)phosphine oxide ligands; organic light-emitting diodes, integrated circuits, organic field-effect transistors, thin-film transistors, organic solar cells, and/or laser diodes
06/01/2010US7728005 such as N-(2-bromophenyl)-N'-[2-(4-fluorophenoxy)ethyl]urea, having superior antiinflammatory and analgesic activity
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010US7727982 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility
06/01/2010US7727981 monoamidino-containing compounds having good bioavailability and/or solubility, used as potent and specific inhibitors of blood coagulation in mammals, and as therapeutic agents for disease states characterized by coagulation disorders
05/2010
05/27/2010US20100130545 Bridged six-membered ring compounds
05/27/2010US20100130469 2, 6-naphthridine derivatives
05/27/2010US20100127618 Indenochrysene derivative and organic light-emitting device using same
05/26/2010EP1730103B1 Formamide derivatives useful as adrenoceptor
05/26/2010CN1856478B Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases
05/26/2010CN1849117B Entry inhibitors of the HIV virus
05/26/2010CN1826115B Substituted piperidine compounds and methods of their use
05/26/2010CN1549716B 3-substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents
05/26/2010CN1520702B Electroluminescent irisium compounds with fluorinated phenylpyridines, phenylpyridines and phenylquinolines and device made with such compounds
05/26/2010CN1391469B Npyy5拮抗剂 Npyy5 antagonist
05/26/2010CN101058564B Aryl alkyl carbamate derivatives production and use thereof in therapy
05/26/2010CN101045707B Method for synthesising 1-amino-isoquinoline
05/25/2010US7723352 Isoquinolinone potassium channel inhibitors
05/25/2010CA2528232C Novel nitrogen-containing heteroaryl compounds and their use in increasing endogenous erythropoietin
05/20/2010WO2010057101A2 Compounds useful as hiv blockers
05/20/2010WO2010055164A2 Novel inhibitors of flavivirus replication
05/20/2010US20100125140 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
05/20/2010US20100125090 Modulators of ATP-Binding Cassette Transporters
05/20/2010US20100125075 Antibacterial Agents
05/20/2010CA2780624A1 Isoprenyl compounds and methods thereof
05/19/2010EP2185524A1 Novel peptide inhibitors of hepatitis c virus replication
05/19/2010EP2185523A2 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics
05/19/2010EP2185522A1 Gamma secretase modulators
05/19/2010EP2185521A2 Compounds and methods for modulating rho gtpases
05/19/2010EP2185511A2 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
05/18/2010US7718672 Substituted tetrahydroisoquinoline compounds, methods of making, and their use
05/18/2010US7718671 Substituted small-molecule arylthiourea compounds are potent and/or selective inhibitors of viral replication in vivo, particularly Hepatitis C virus replication; e.g., 1-(3-benzyloxy)phenylthiourea; side effect reduction
05/13/2010US20100120845 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
05/13/2010US20100120844 Tetrahydroisoquinoline compound
05/13/2010US20100120810 Compounds and methods for modulating rho gtpases
05/13/2010US20100120802 Novel Anti-Inflammatory and Analgesic Heterocyclic Amidines that Inhibit Nitrogen Oxide (NO) Production
05/13/2010US20100120759 Azadecalin glucocorticoid receptor modulators
05/13/2010US20100120669 Thiadiazole derivatives, inhibitors of stearoyl-coa desaturase
05/12/2010EP2184073A1 Therapeutic agent for cancer with resistance to protease inhibitor
05/12/2010EP2183218A2 Novel b1 antagonists
05/12/2010EP2183217A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
05/12/2010CN101704810A Cycloalkyl inhibitors of potassium channel function
05/12/2010CN101704783A Preparation method of dauricine
05/11/2010US7713994 Anticancer agents; cyclin dependent kinase inhibitors; (4Z)-6-[(3-aminophenyl)amino]-4-(([4-(piperidin-1-ylmethyl)phenyl]amino)methylene)isoquinoline-1,3(2H,4H)-dione for example
05/06/2010WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/06/2010WO2010028004A3 Substituted berbines and processes for their synthesis
05/06/2010WO2010027746A3 Hedgehog pathway modulators
05/06/2010US20100113511 Mono Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors
05/06/2010US20100113488 Macrocyclic factor viia inhibitors useful as anticoagulants
05/06/2010US20100113435 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1
05/06/2010US20100112545 Trans-1,2-diphenylethlene derivatives and nanosensors made therefrom
05/05/2010CN1832925B New P2X7 receptor avtagonists and their use
05/04/2010US7709501 Vanilloid receptor ligands and their use in treatments
05/04/2010US7709476 6-Methoxy-3-(methoxymethyl)-2-methyl-4-phenylisoquinolin-1(2H)-one; treat cardiac arrhythmias
04/2010
04/29/2010WO2010045948A1 Isoquinolinone derivatives as nk3 antagonists
04/29/2010US20100105894 Cyclopropane compounds and pharmaceutical use thereof
04/29/2010US20100105725 Antidiabetic bicyclic compounds
04/29/2010US20100105654 Substituted quinazolinone compounds
04/29/2010CA2739946A1 Isoquinolinone derivatives as nk3 antagonists
04/28/2010EP1590321B1 Aryl alkyl carbamate derivatives production and use thereof in therapy
04/28/2010CN1759120B Metal complexes
04/27/2010US7705017 Compounds for treatment of neurodegenerative diseases
04/27/2010CA2493667C Vanilloid receptor ligands and their use in treatments
04/27/2010CA2462939C Novel derivatives of isoquinoline, process for their preparation and pharmaceutical compositions containing them
04/27/2010CA2345118C Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
04/22/2010WO2010042998A1 S1p receptors modulators
04/22/2010WO2010027889A3 Process for synthesizing substituted isoquinolines
04/22/2010US20100099878 (1r, 1'r)-atracurium salts separation process
04/22/2010US20100099702 Therapeutic agent for neuropathic pain
04/22/2010US20100099665 Isoquinolinone derivatives
04/22/2010US20100099663 4-trifluoromethoxyphenoxybenzol-4'-sulfonic acids, method for the production and use thereof in medicaments
04/22/2010CA2739901A1 S1p receptors modulators
04/21/2010EP2176227A1 Process for producing cisatracurium and associated intermediates
04/21/2010EP2176226A1 Method for making tetrabenazine compounds
04/21/2010EP1258252B1 Integrin expression inhibitors
04/21/2010CN101696188A Trifluoromethyl substituted benzamides as kinase inhibitors
04/20/2010US7700794 Fluorous tagging compounds and methods of increasing the fluorous nature of compounds
04/20/2010US7700604 (5S)-5-methyl-5-({[6-[2-(trifluoromethyl)pyrimidin-5-yl]-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)imidazolidine-2,4-dione; asthma, rhinitis, chronic obstructive pulmonary diseases (COPD), arthritis (such as rheumatoid arthritis and osteoarthritis), atherosclerosis, cancer
04/15/2010US20100094017 Using alkylmetal reagents for directed metalation of azaaromatics
04/15/2010US20100094014 Excitatory amino acid receptor antagonists
04/15/2010US20100093790 Isoquinoline compounds
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 119